January 21, New Delhi According to new data presented at the current World Economic Forum (WEF) on Tuesday, addressing nine important health issues may be essential for women’s health and contribute the equivalent of 2.5 healthy days per woman annually.

According to the latest data, women spend a quarter more of their lives in bad health than men do. The answer to improving their lives and health may lie in concentrating on the nine conditions that are categorized as lifespan and healthspan conditions.

According to the report, which was released in partnership with the McKinsey Health Institute (MHI), “the nine conditions are divided into lifespan conditions, related to the total number of years lived (maternal hypertensive disorders, postpartum hemorrhage, ischemic heart disease, cervical cancer, and breast cancer) and health span conditions, related to how many of those years are healthy (endometriosis, menopause, migraine, and premenstrual syndrome).”

According to the research, focused efforts on these nine major health issues might reduce the worldwide disease burden by 27 million disability-adjusted life years and contribute 2.5 healthy days annually per woman.

It also emphasized the enormous financial returns on investments made in women’s health. According to the paper, addressing the nine factors may also change millions of lives and release $400 billion in global GDP annually by 2040.

Head of the Center for Health and Healthcare and WEF Executive Committee member Shyam Bishen said, “Measuring progress is essential for driving meaningful change and developing effective healthcare strategies tailored to women.”

Because there is a dearth of sex-specific research, women are often disregarded despite the potential to add 2.5 more healthy days to their lives; just 10% of clinical trials for migraine and ischemic heart disease provide such data, she said.

The Women’s Health Impact Tracking (WHIT), a publicly available tool created to evaluate and solve global health inequalities and promote equitable, scalable solutions globally, is being launched by the Forum in partnership with MHI as part of this effort.

Due to deficiencies in data collecting, research funding, clinical practice standards, and healthcare delivery systems, there have been significant discrepancies in women’s health outcomes worldwide. Remarkably, just 23% of therapeutic trials concentrate on low- and middle-income countries, despite the fact that 54% of the health burden for women occurs there.

The study emphasized that these gaps might be considerably decreased by strengthening sex-based therapeutic standards, expanding research funding for illnesses unique to women, and improving data accuracy. According to Lucy Perez, Senior Partner at McKinsey & Company and Co-leader of the McKinsey Health Institute, “it is time to count women, study women, care for women, invest in women, and include all women.”

In addition to improving the lives of millions of women and generating $400 billion in economic benefits, addressing these nine problems offers a roadmap for scaling and monitoring advancements in order to reduce the wider disparity in women’s health, Perez said.

From January 20 to 24, the WEF Annual Meeting 2025 will take place in Davos-Klosters, Switzerland. ‘Collaboration for the Intelligent Age’ is the subject under which world leaders are discussing a number of concerns.